Ovid Therapeutics Inc. Recorded Big Gain
Wed, Aug 13, 2025 at 07:44 PM
Ovid Therapeutics Inc. (OVID:NASDAQ) soared at $0.86, representing a gain of 56.9%. On Wed, Aug 13, 2025, OVID:NASDAQ touched a New 2-Week High of $0.86. The stock appeared on our News Catalysts scanner on Wed, Aug 13, 2025 at 02:37 PM in the 'MISCELLANEOUS' category. From Wed, Jul 30, 2025, the stock recorded 30.00% Up Days and 45.45% Green Days
About Ovid Therapeutics Inc. (OVID:NASDAQ)
Ovid Therapeutics Inc is a US-based biopharmaceutical company. The firm is engaged primarily in developing medicines for patients suffering with rare neurological disorders.
Top 10 Gainers:
- Bolt Projects Holdings, Inc. (BSLK:NASDAQ), 556.88%
- SRAX, Inc. (SRAX:NASDAQ), 138.1%
- WEBTOON Entertainment Inc. (WBTN:NASDAQ), 81.2%
- Momentus Inc. (MNTS:NASDAQ), 72.07%
- Generation Bio Co. (GBIO:NASDAQ), 63.21%
- Ovid Therapeutics Inc. (OVID:NASDAQ), 56.86%
- Sapiens International Corporation N.V. (SPNS:NASDAQ), 44.27%
- Safety Shot, Inc. (SHOT:NASDAQ), 41.35%
- Mobile-health Network Solutions (MNDR:NASDAQ), 39.33%
- Paramount Skydance Corporation (PSKY:NASDAQ), 36.74%